Managing Survivorship after Hematopoietic Cell Transplantation.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 3, p. 75, doi. 10.1007/s11899-023-00694-8
- By:
- Publication type:
- Article
Works matching IS 15588211 AND DT 2023 AND VI 18 AND IP 3
Results: 5
1
2
Therapeutic Targets in Myelodysplastic Neoplasms: Beyond Hypomethylating Agents.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 3, p. 56, doi. 10.1007/s11899-023-00693-9
- By:
- Publication type:
- Article
3
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 3, p. 83, doi. 10.1007/s11899-023-00692-w
- By:
- Publication type:
- Article
4
Approach to the Treatment of Philadelphia Chromosome-Negative B-cell ALL in Older Adults: Is Age Becoming just a Number?
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 3, p. 68, doi. 10.1007/s11899-023-00691-x
- By:
- Publication type:
- Article
5
Targeted Therapy for MPNs: Going Beyond JAK Inhibitors.
- Published in:
- Current Hematologic Malignancy Reports, 2023, v. 18, n. 3, p. 41, doi. 10.1007/s11899-023-00690-y
- By:
- Publication type:
- Article